investment.com

Apogee Therapeutics, Inc. — insider transactions

11 transactions on record · APGE · CIK 1974640

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
11
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
4
Bought, 3m
$0
Sold, 3m
$4.5M
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$2.7M
2026-07-08
Director share, 12m
54.5%
of transactions where role is stated
Current run
11 sells
consecutive same-direction transactions
Net 3m flow
-$4.5M
purchases minus sales
Total on record
11

Transactions

11 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-08-112026-08-074Harwin Peter EvanDirectorExercise of derivative10,370$43.85$454.7Kfiling
2026-08-112026-08-074Harwin Peter EvanDirectorExercise of derivative31,838$0.00—filing
2026-08-112026-08-074Harwin Peter EvanDirectorExercise of derivative31,838$17.00$541.2Kfiling
2026-08-112026-08-074Harwin Peter EvanDirectorExercise of derivative10,370$0.00—filing
2026-08-072026-08-052Dambkowski CarlChief Medical OfficerOpen market sale5,500$134.17$737.9Kfiling
2026-08-072026-08-052Dambkowski CarlChief Medical OfficerExercise of derivative4,125$0.00—filing
2026-08-072026-08-052Dambkowski CarlChief Medical OfficerExercise of derivative4,125$22.86$94.3Kfiling
2026-07-242026-07-240Henderson JaneChief Financial OfficerGift15,000$0.00—filing
2026-07-162026-07-142Dambkowski CarlChief Medical OfficerGift8,000$0.00—filing
2026-07-102026-07-100HENDERSON MICHAEL THOMASDirector, Chief Executive OfficerGift75,046$0.00—filing
2026-07-102026-07-082HENDERSON MICHAEL THOMASDirector, Chief Executive OfficerOpen market sale20,000$133.63$2.7Mfiling

Source: U.S. Securities and Exchange Commission, EDGAR

Apogee Therapeutics, Inc. insider transactions — 11 filings on record — investment.com